Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Net Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   EV/Net Sales(x) 3.334.012.814.430.86

What is the latest EV/Net Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Net Sales ratio of SYNCOM FORMULATIONS (INDIA) is 3.33 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20253.33
Mar20244.01
Mar20232.81
Mar20224.43
Mar20170.86

How is EV/Net Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Net Sales % Change
Mar2025 3.33
-16.96
Mar2024 4.01
42.70
Mar2023 2.81
-36.57
Mar2022 4.43
415.12
Mar2017 0.86 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Net Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,298.1 Cr -6.1% 3.3% -8.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,032.0 Cr 0.9% 12.8% 4.6% Stock Analytics
DIVIS LABORATORIES ₹183,759.0 Cr 3.2% 14% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,224.0 Cr 0.7% 5.5% 36.9% Stock Analytics
CIPLA ₹116,214.0 Cr 6.8% 18.8% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹108,739.0 Cr 0.7% 5.5% 9.4% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-6.1%

3.3%

-8.6%

SENSEX

-3.1%

-2.8%

-6.1%


You may also like the below Video Courses